Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomography/computed tomography - A prospective study

被引:83
作者
Risum, S. [1 ]
Hogdall, C. [2 ]
Loft, A. [3 ]
Berthelsen, A. K. [3 ]
Hogdall, E. [4 ]
Nedergaard, L. [5 ]
Lundvall, L. [2 ]
Engelholm, S. A. [1 ]
机构
[1] Copenhagen Univ Hosp, Finsen Ctr, Dept Oncol, Rigshosp, Copenhagen, Denmark
[2] Copenhagen Univ Hosp, Rigshosp, Juliane Marie Ctr, Copenhagen, Denmark
[3] Copenhagen Univ Hosp, Rigshosp, Ctr Diagnost Invest, Dept Clin Physiol & Nucl Med,PET & Cyclotron Unit, Copenhagen, Denmark
[4] Danish Canc Soc, Inst Canc Epidemiol, Dept Virus Hormones & Canc, Copenhagen, Denmark
[5] Copenhagen Univ Hosp, Ctr Diagnost Invest, Dept Pathol, Copenhagen, Denmark
关键词
positron emission tomography; prediction of optimal cytoreduction; surgery; primary ovarian cancer;
D O I
10.1016/j.ygyno.2007.11.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To prospectively identify combined PET/CT predictors of incomplete/suboptimal primary cytoreduction in advanced ovarian cancer. Methods. From September 2004 to March 2007, 179 patients with a Risk of Malignancy Index (RMI) >150 based on serum CA-125, ultrasound examinations and menopausal state, underwent PET/CT within 2 weeks prior to standard surgery/debulking of a pelvic tumor. Ten PET/CT features were identified and evaluated as predictors of cytoreduction in 54 patients with advanced ovarian cancer. Results. Complete cytoreduction (no macroscopic residual disease) was achieved in 35% and optimal cytoreduction (<1 cm residual disease) was achieved in 56%. Using univariate analysis, predictors of incomplete cytoreduction were large bowel mesentery implants (LBMI) (P<0.003), pleural effusion (P<0.009), ascites (P<0.009) and peritoneal carcinosis (P<0.01). LBMI (P<0.03) and ascites (P<0.05) were also predictors of suboptimal cytoreduction. Using multivariate analysis, LBMI was the only independent predictor of incomplete cytoreduction (P=0.004) and no predictor of suboptimal cytoreduction was found. Conclusion. PET/CT predictors of cytoreduction were found. But they should not be used to withhold patients form primary cytoreductive surgery. We suggest PET/CT as a supplementary image modality prior to surgery in primary OC patients whenever accurate and comprehensive preoperative evaluation of primary tumor and metastases is desired. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:265 / 270
页数:6
相关论文
共 34 条
[1]   Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (02) :283-287
[2]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[3]  
Ansquer Y, 2001, CANCER, V91, P2329, DOI 10.1002/1097-0142(20010615)91:12<2329::AID-CNCR1265>3.0.CO
[4]  
2-U
[5]   Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer [J].
Axtell, Allison E. ;
Lee, Margaret H. ;
Bristow, Robert E. ;
Dowdy, Sean C. ;
Cliby, William A. ;
Raman, Steven ;
Weaver, John P. ;
Gabbay, Mojan ;
Ngo, Michael ;
Lentz, Scott ;
Cass, Ilana ;
Li, Andrew J. ;
Karlan, Beth Y. ;
Holschneider, Christine H. .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (04) :384-389
[6]   TUMOR REDUCTION SURGERY AND LONG-TERM SURVIVAL IN ADVANCED OVARIAN-CANCER - A DACOVA STUDY [J].
BERTELSEN, K .
GYNECOLOGIC ONCOLOGY, 1990, 38 (02) :203-209
[7]   Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer [J].
Bristow, RE ;
Montz, FJ ;
Lagasse, LD ;
Leuchter, RS ;
Karlan, BY .
GYNECOLOGIC ONCOLOGY, 1999, 72 (03) :278-287
[8]  
Bristow RE, 2000, CANCER, V89, P1532, DOI 10.1002/1097-0142(20001001)89:7<1532::AID-CNCR17>3.0.CO
[9]  
2-A
[10]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259